ALIF_B: Strong margin and profit growth, with net debt/EBITDA reduced to 2.9 and robust segment performance

About this update from Addlife Ab Class B

EBITA margin and profit improved significantly, with strong organic growth and cost control driving a 164% increase in profit before tax year-over-year. Net debt/EBITDA fell to 2.9, and both Labtech and Medtech segments saw margin gains and healthy demand.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Addlife Ab Class B